Pinkas Jan 4
4 · CRESCENT BIOPHARMA, INC. · Filed Jul 16, 2025
Insider Transaction Report
Form 4
Pinkas Jan
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-07-16+142,474→ 142,474 totalExercise: $13.14Exp: 2035-07-16→ Ordinary Shares (142,474 underlying)
Footnotes (1)
- [F1]This option will vest as to 25% on July 7, 2026 and in equal monthly installments thereafter through July 7, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date.